Cargando…

A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma

BACKGROUND: Long non-coding RNAs (lncRNA) have been implicated in a hand of studies that supported an involvement and co-operation in Uterine Corpus Endometrial Carcinoma (UCEC). Enhancer RNAs (eRNA), a functional subtype of lncRNA, have a key role throughout the genome to guide protein production,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jinhui, Yin, Jian, Wang, Yuanyuan, Cai, Lixin, Geng, Rui, Du, Mulong, Zhong, Zihang, Ni, Senmiao, Huang, Xiaohao, Yu, Hao, Bai, Jianling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284715/ https://www.ncbi.nlm.nih.gov/pubmed/35836132 http://dx.doi.org/10.1186/s12575-022-00172-0

Ejemplares similares

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients
por: Jiao, Yang, et al.
Publicado: (2023)

Crosstalk of Redox-Related Subtypes, Establishment of a Prognostic Model and Immune Responses in Endometrial Carcinoma
por: Geng, Rui, et al.
Publicado: (2022)

Identification of Specific Cervical Cancer Subtypes and Prognostic Gene Sets in Tumor and Nontumor Tissues Based on GSVA Analysis
por: Zhong, Zihang, et al.
Publicado: (2022)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Comprehensive landscape of the functions and prognostic value of RNA binding proteins in uterine corpus endometrial carcinoma
por: Yao, Yong, et al.
Publicado: (2022)

Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes
por: Liu, Jinhui, et al.
Publicado: (2021)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer
por: Geng, Rui, et al.
Publicado: (2022)

Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
por: Geng, Rong, et al.
Publicado: (2020)

Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer
por: Liu, Jinhui, et al.
Publicado: (2022)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022)

Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer
por: Liu, Jinhui, et al.
Publicado: (2022)

Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC
por: Liu, Jinhui, et al.
Publicado: (2022)

Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma
por: Fang, Xiangming, et al.
Publicado: (2023)

Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2020)

ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model
por: Cui, Yun-Qian, et al.
Publicado: (2021)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
por: Chen, Yun
Publicado: (2022)

A prognostic model and immune regulation analysis of uterine corpus endometrial carcinoma based on cellular senescence
por: Gao, Lulu, et al.
Publicado: (2022)

MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma
por: Chen, Junyu, et al.
Publicado: (2023)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

COVID-19–associated lncRNAs as predictors of survival in uterine corpus endometrial carcinoma: A prognostic model
por: Ding, Yang, et al.
Publicado: (2022)

PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023)

Comprehensive Analysis of a Novel Lipid Metabolism-Related Gene Signature for Predicting the Prognosis and Immune Landscape in Uterine Corpus Endometrial Carcinoma
por: Tan, Xiaofang, et al.
Publicado: (2022)

Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer
por: Geng, Rui, et al.
Publicado: (2023)

Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma
por: Guo, Chenrui, et al.
Publicado: (2022)

Does tumor size have prognostic value in patients undergoing lymphadenectomy in endometrioid-type endometrial cancer confined to the uterine corpus?
por: ÇAKIR, Caner, et al.
Publicado: (2019)

Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma
por: Wei, Sitian, et al.
Publicado: (2022)

Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis
por: Zhao, Junde, et al.
Publicado: (2022)

Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma
por: Cai, Yiran, et al.
Publicado: (2022)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma
por: Zhong, Zhenglan, et al.
Publicado: (2022)

Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis
por: Miao, Chenyun, et al.
Publicado: (2021)

Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma?
por: Song, Changho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5rll4ojg2ddbt315o7b7srfh8k